Commonly reported side effects of topotecan include: febrile neutropenia, sepsis, infection, abdominal pain, alopecia, anemia, asthenia, constipation, dyspnea, fatigue, fever, headache, leukopenia, nausea, neutropenia, stomatitis, thrombocytopenia, vomiting, granulocytopenia, diarrhea, and anorexia. Other side effects include: febrile neutropenia, increased serum alanine aminotransferase, increased serum aspartate aminotransferase, intestinal obstruction, pain, and paresthesia.  See below for a comprehensive list of adverse effects.
Other dosage forms:
As well as its needed effects, topotecan may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking topotecan, check with your doctor immediately:
Some topotecan side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
The most common adverse events were hematologic: neutropenia, leukopenia, anemia, and thrombocytopenia.
Very common (10% or more): Neutropenia (up to 97%), leukopenia (97%), anemia (up to 94%), thrombocytopenia (up to 74%), pyrexia/grade 4 neutropenia (28%), febrile neutropenia (28%), hemorrhage (15%)Common (1% to 10%): Pancytopenia, coagulation adverse eventPostmarketing reports: Severe bleeding (in association with thrombocytopenia)
Very common (10% or more): Nausea (64%), other gastrointestinal adverse event (63%), vomiting (45%), diarrhea (32%), constipation (29%), abdominal pain (22%), stomatitis (18%)Common (1% to 10%): Abdominal pain, intestinal obstruction, dyspepsiaFrequency not reported: Neutropenic colitisPostmarketing reports: Abdominal pain potentially associated with neutropenic colitis
Rash includes pruritus, rash erythematous, urticaria, dermatitis, bullous eruption, and maculopapular rash.
Very common (10% or more): Alopecia (49%), dermatologic adverse reaction (48%), rash (16%)Common (1% to 10%): PruritusFrequency not reported: UrticariaPostmarketing reports: Angioedema, severe dermatitis, severe pruritus
Very common (10% or more): Sepsis or pyrexia/infection with neutropenia (43%), infection-febrile neutropenia (28%), infection (27%)Common (1% to 10%): Pneumonia, allergy-immunology adverse event, pharyngitis, rhinitis, sepsis
Pain includes abdominal pain or cramping, arthralgia, bone pain, chest pain (non-cardiac and non-pleuritic), dysmenorrhea, dyspareunia, earache, headache, hepatic pain, myalgia, neuropathic pain, pain due to radiation, pelvic pain, pleuritic pain, rectal or perirectal pain, tumor pain, body pain, back pain, and skeletal pain."Constitutional" is a composite term that includes fatigue (lethargy, malaise, asthenia), fever (in the absence of neutropenia), rigors, chills, sweating, and weight gain or loss.
Very common (10% or more): Constitutional (69%), pain (up to 59%), fatigue (29%), pyrexia (28%), asthenia (25%), mucositis (14%)Common (1% to 10%): Treatment related death, malaise
Very common (10% or more): Dyspnea (22%), pulmonary adverse event (17%), coughing (15%)Common (1% to 10%): Epistaxis, respiratory disorderRare (less than 0.1%): Interstitial lung diseasePostmarketing reports: Fatal interstitial lung disease
Very common (10% or more): Hepatic adverse event (24%)Common (1% to 10%): Transient elevations in hepatic enzymes, hyperbilirubinemia, elevated ALT, elevated AST
Very common (10% or more): Non-neuropathy neurologic adverse event (35%), headache (18%)Common (1% to 10%): Paresthesia, neuropathy, dizzinessUncommon (0.1% to 1%): Hypoesthesia, peripheral neuropathy, paresis
Very common (10% or more): Cardiovascular adverse event (25%)
Very common (10% or more): Metabolic-laboratory adverse event (39%), anorexia (19%)Frequency not reported: Dehydration
Very common (10% or more): Musculoskeletal adverse event (14%)
Common (1% to 10%): Hypersensitivity (including rash)Postmarketing reports: Allergic manifestations, anaphylactoid reactions
Very common (10% or more): Genitourinary adverse event (36%)Common (1% to 10%): Sexual reproduction function adverse event
Rare (less than 0.1%): ExtravasationPostmarketing reports: Inadvertent extravasation
Common (1% to 10%): Endocrine adverse event
Common (1% to 10%): Ocular-visual adverse event
It is possible that some side effects of topotecan may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
intravenous powder for solution, intravenous solution
Black, tarry stools
bleeding gums
blood in the urine or stools
chest pain
chills
cough
fever
lower back or side pain
painful or difficult urination
pale skin
pinpoint red spots on the skin
shortness of breath
sore throat
sores, ulcers, or white spots on the lips or in the mouth
swollen glands
troubled breathing with exertion
unusual bleeding or bruising
unusual tiredness or weakness
Diarrhea
hair loss or thinning of the hair
lack or loss of strength
loss of appetite
nausea
vomiting
weight loss